Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BESPONSA® INJECTION 1 MG SPECIAL INVESTIGATION

NCT05923112 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05923112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05923112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BESPONSA® INJECTION 1 MG SPECIAL INVESTIGATION
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 2, 2018
Completion date
September 6, 2024
Enrollment
421 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia